AH
Ahmed H. Hassan

Publications (6)

The effect of combination treatment with casirivimab and imdevimab versus standard antiviral therapy on clinical outcomes in hospitalized COVID-19 patients
Article scientifique · 2024
Review of: "[Review Article] Independent Analysis of the Results of the First Infant Immunization Campaign with Beyfortus® (Nirsevimab, Monoclonal Antibody Against RSV Bronchiolitis Virus): Mixed Results, Identification of Biases, and Possible Role and Mechanisms of ADE (Antibody Dependent Enhancement)"
Rapport d'évaluation · 2024
Atorvastatin for reduction of 28-day mortality in severe and critical COVID-19 patients: a randomized controlled trial
Article scientifique · 2024
Atorvastatin for Reduction of 28-day Mortality in Sever and Critical COVID-19 Patients: A Randomized Controlled Trial
Article scientifique · 2023
Study to compare the Possible Efficacy and Safety of casirivimab and imdevimab combination versus standard antiviral therapy in hospitalized COVID-19 patients
Article scientifique · 2022
Clinical Study to Evaluate the Possible Efficacy and Safety of Antibodies Combination (casirivimab and imdevimab) versus standard antiviral therapy as antiviral agent against Corona virus 2 infection in hospitalized COVID-19 patients
Article scientifique · 2022

Domaines principaux

Sciences de la santé6

Statistiques

Consultations2
Téléchargements0